Brookfield Corporation heads into its July 16 earnings with a cluster of insider selling and a stock that has quietly slipped 3.1% on the week — a more interesting setup than the near-dormant short data suggests.
The insider story is the standout this week. Two senior figures sold material amounts into the recent pullback. Director Jack Cockwell sold roughly 269,000 shares across June 23–24, generating just over CAD $17 million in proceeds at prices around CAD $61.50–$62.37. Executive Vice Chairman Jeffrey Blidner sold a further 31,600 shares across June 17–18 at prices in the CAD $62.70–$63.93 range. Both were selling as the stock traded above current levels — BN closed Tuesday at CAD $60.51, below every price at which they sold. The 90-day net insider figure is technically positive at around 603,000 shares, but that reflects earlier buying activity. The recent directional signal from named executives is plainly one of distribution, not accumulation, and the timing — within two weeks of the next earnings — is worth noting.
The lending market offers no tension to speak of. Short interest is just 0.26% of the free float, a level so thin it carries no meaningful signal. That figure has also fallen by more than a fifth over the past month, dropping from roughly 7.4 million shares in late May to 5.8 million now. Borrowing costs are negligible at 0.55%, and availability is essentially unlimited — the lending pool is barely touched. This is not a stock where the short side is doing anything interesting. The ORTEX short score of 26.6, ranking in the 88th percentile of its peer universe for "low short pressure," confirms the picture. Positioning here is entirely a long-side story.
The Street picture is mixed but not alarming. BN trades at a price-to-earnings multiple of around 36x and an EV/EBITDA of 36.5x — premium valuations for an asset manager, though both multiples have eased modestly over the past 30 days as the stock has drifted lower. The price-to-book ratio of 2.1x has come in as well. On factor scores, the dividend rank is exceptional at the 94th percentile, which makes sense given Brookfield's yield-oriented investor base, while EPS surprise ranks poorly at the 14th percentile — meaning the company has a history of modest or below-consensus earnings beats relative to peers. No recent analyst changes are available in the data, so the Street consensus cannot be updated here.
Peer performance adds a useful frame. Closest correlate BAM fell harder on the week, down 4.6% versus BN's 3.1% decline. ARES dropped an even sharper 7.8%. On the other side, TPG gained 2.5%, the only name in the peer group to close the week in positive territory. The alternative asset manager group has broadly sold off, suggesting macro or sector-level pressure rather than a BN-specific story — though BN's insider activity adds an idiosyncratic layer that peers lack.
The July 16 earnings print is the next focal point. The last reported earnings reaction on May 14 produced a single-day move of just +1.2%, and a five-day follow-through of roughly +1.1% — suggesting the market has historically treated BN results as low-volatility events. Whether the insider selling ahead of this print reflects routine tax or estate planning, or something more pointed about near-term expectations, is what the numbers alone cannot answer.
See the live data behind this article on ORTEX.
Open BN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
